1. Home
  2. DAIO vs BIVI Comparison

DAIO vs BIVI Comparison

Compare DAIO & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAIO
  • BIVI
  • Stock Information
  • Founded
  • DAIO 1969
  • BIVI 2013
  • Country
  • DAIO United States
  • BIVI United States
  • Employees
  • DAIO N/A
  • BIVI N/A
  • Industry
  • DAIO Electrical Products
  • BIVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • DAIO Industrials
  • BIVI Health Care
  • Exchange
  • DAIO Nasdaq
  • BIVI Nasdaq
  • Market Cap
  • DAIO 22.0M
  • BIVI 18.6M
  • IPO Year
  • DAIO N/A
  • BIVI N/A
  • Fundamental
  • Price
  • DAIO $3.16
  • BIVI $0.98
  • Analyst Decision
  • DAIO Strong Buy
  • BIVI
  • Analyst Count
  • DAIO 1
  • BIVI 0
  • Target Price
  • DAIO $4.00
  • BIVI N/A
  • AVG Volume (30 Days)
  • DAIO 35.6K
  • BIVI 207.2K
  • Earning Date
  • DAIO 07-24-2025
  • BIVI 05-12-2025
  • Dividend Yield
  • DAIO N/A
  • BIVI N/A
  • EPS Growth
  • DAIO N/A
  • BIVI N/A
  • EPS
  • DAIO N/A
  • BIVI N/A
  • Revenue
  • DAIO $21,846,000.00
  • BIVI N/A
  • Revenue This Year
  • DAIO $7.06
  • BIVI N/A
  • Revenue Next Year
  • DAIO $5.39
  • BIVI N/A
  • P/E Ratio
  • DAIO N/A
  • BIVI N/A
  • Revenue Growth
  • DAIO N/A
  • BIVI N/A
  • 52 Week Low
  • DAIO $1.88
  • BIVI $0.62
  • 52 Week High
  • DAIO $3.21
  • BIVI $7.50
  • Technical
  • Relative Strength Index (RSI)
  • DAIO 68.30
  • BIVI 42.25
  • Support Level
  • DAIO $3.01
  • BIVI $0.88
  • Resistance Level
  • DAIO $3.12
  • BIVI $1.03
  • Average True Range (ATR)
  • DAIO 0.13
  • BIVI 0.07
  • MACD
  • DAIO 0.01
  • BIVI -0.02
  • Stochastic Oscillator
  • DAIO 90.50
  • BIVI 23.97

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: